The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Shrewsbury Stephen B since 2021.
This trader's CIK number is 1413821.
At the time of last reporting, Shrewsbury Stephen B was the Chief Medical Officer of Impel Neuropharma Inc. (stock ticker symbol IMPL).
Also see all insider trading activities at Impel Neuropharma Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | IMPL | 0 | $0 | 0 | $0 | 24,606 | $48,473 |
| 2021 | IMPL | 0 | $0 | 0 | $0 | 73,384 | $180,524 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-03-29 | IMPL | Option Ex | 24,606 | 1.97 | 48,473 |
| 2021-09-21 | IMPL | Option Ex | 73,384 | 2.46 | 180,524 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Shrewsbury Stephen B (Chief Medical Officer of Impel Neuropharma Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.